Procyrion

Today we honor #WorldKidneyDay a global reminder of the critical role kidney health plays in overall cardiovascular well-being. At Procyrion, we remain committed to advancing research through the DRAIN-HF pivotal trial, evaluating how the Aortix pump may support both cardiac output and renal function in patients with advanced heart failure. #WorldKidneyDay #KidneyHealth #HeartFailure #DRAINHF #Aortix #CardiorenalSyndrome #DiureticResistance #Innovation

Will you be at the Houston Shock Symposium? Stop by the Procyrion table (number 143) to meet our team and discuss the DRAIN-HF pivotal trial and the potential of the Aortix pump for patients with acute decompensated heart failure. #HoustonShockSymposium2026 #DRAINHF #Aortix #HeartFailure #CardiorenalSyndrome #DiureticResistance #Innovation

The Procyrion team has a busy week coming up and is looking forward to connecting with clinicians, innovators and industry colleagues at THT 2026 and the Houston Shock Symposium. We’ll be available to discuss our DRAIN-HF pivotal trial evaluating the Aortix pump as a potential new approach for patients with acute decompensated heart failure and cardiorenal syndrome. Message us if you’ll be at either meeting and want to connect. We look forward to great conversations and learning about the latest in heart failure care! #THT2026 #HoustonShockSymposium2026 #DRAINHF #Aortix #HeartFailure #CardiorenalSyndrome #DiureticResistance #Innovation

Heart Failure Awareness Week is a reminder of the importance of collaborative, innovative research. We’re proud to work alongside leading physicians, research coordinators, and hospitals participating in the DRAIN-HF pivotal trial. Their commitment to advancing treatment options is helping us better understand how the Aortix pump could benefit patients living with acute decompensated heart failure complicated by cardiorenal syndrome. A huge THANK YOU to every site contributing to this important work. Your expertise is helping reshape what’s possible in heart failure care. #HFWeek2026 #HeartFailure #DRAINHF #Aortix #cardiorenalsyndrome #diureticresistance #heartfailure #clinicaltrials #innovation

Congrats to the team at Tallahassee Research Institute on enrolling the first DRAIN-HF patient of 2026! We are grateful to the amazing team of Dr. Andres Vargas Estrada, Dr. Bill Dixon, Dr. Gian-Carlo Giove, Dr. John Katopodis, Andrea Tunnicliff, and Austin Allen for your commitment to advance treatment options for heart failure patients. We look forward to your continued success in this groundbreaking study for patients with acute decompensated heart failure. #DRAINHF #Aortix #cardiorenalsyndrome #diureticresistance #heartfailure #clinicaltrials #innovation

As the year comes to a close, we want to thank the clinicians, researchers, trial sites, partners, and patients who continue to inspire our work every day. Your dedication and collaboration are the foundation of our progress as we advance the DRAIN-HF pivotal trial and the development of the Aortix pump. This season is a time for reflection, gratitude, and hope. We’re proud to work alongside such an extraordinary community and remain committed to improving care for patients with acute decompensated heart failure and cardiorenal syndrome. Wishing you and your loved ones a joyous holiday season and a healthy, hopeful New Year.

New DRAIN-HF site alert! Congrats to the team at @NorthwellHealth Staten Island on enrolling your first patient in the DRAIN-HF trial. We are grateful to the amazing team of Dr. Spencer Liu, Dr. Mitchell Weinberg, Sammi Ruan and Reina Mae White for your commitment to advance treatment options for heart failure patients and look forward to working with you on this groundbreaking study for patients with acute decompensated heart failure. #DRAINHF #Aortix #cardiorenalsyndrome #diureticresistance #heartfailure #clinicaltrials #innovation

Today we want to shine a spotlight on Theresa Grandoff, a research coordinator at the University of South Florida (@USouthFlorida) - Tampa General Hospital (@TGHCares), whose dedication has been nothing short of extraordinary. USF is currently the top enrolling site in the DRAIN-HF pivotal trial, a milestone made possible by Theresa's commitment, attention to detail, and unwavering passion for advancing treatment options for patients with acute decompensated heart failure. From coordinating complex trial workflows to keeping the entire team moving forward, she consistently goes above and beyond. Her work embodies the very best of clinical research and drives real progress for the heart failure community. Thank you Theresa for everything you do, and thank you to the entire USF team for your incredible partnership and leadership in DRAIN-HF. #Aortix #heartfailure #cardiorenalsyndrome #diureticresistance #DRAINHF #clinicaltrials #innovation

We're excited to welcome Andrew Davis as Procyrion's new 𝗖𝗵𝗶𝗲𝗳 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗢𝗳𝗳𝗶𝗰𝗲𝗿! Andy brings 25+ years of medical device leadership, with deep expertise in launching innovative cardiovascular therapies that expand patient access and address significant unmet needs. Before joining Procyrion, Andy served as Chief Commercial Officer at Silk Road Medical, where he led the go-to-market strategy for TCAR, resulting in the company's acquisition by Boston Scientific. His experience also includes:   • 15 years at Medtronic, leading commercial teams across TAVR, EVAR/TEVAR, Peripheral Vascular, and Spine/Biologics   • Senior roles at Endologix and 3M's Advanced Wound Therapy Group   • A strong track record building teams, driving clinical adoption, and scaling transformative technologies Andy joins Procyrion at a pivotal moment as we continue working with sites and clinicians to drive enrollment in the DRAIN-HF pivotal trial. His leadership will help lay the groundwork needed to bring the Aortix pump to patients with acute decompensated heart failure in the future. Please join us in welcoming Andy to the Procyrion team!

This Thanksgiving, our gratitude goes out to the entire DRAIN-HF community. Thank you to all our DRAIN-HF sites, dedicated research teams, and the patients and families participating in this pivotal trial. Your commitment, expertise, and partnership are driving meaningful advances for patients with acute decompensated heart failure and cardiorenal syndrome. We’re inspired everyday by the progress we're making together and grateful for your collaboration and belief in the potential of Aortix. Wishing everyone a wonderful and restorative Thanksgiving.

New DRAIN-HF site alert! We're excited to announce that the team at Banner-University Medical Center Phoenix has enrolled their first patient in the DRAIN-HF study. Congrats to Dr. I-Hui (Ann) Chiang, site PI, and the talented team of Dr. Saroj Neupane (@SarojNeupaneMD), Dr. Radha Gopalan (@SecondOpinion25), MD, Dr. Anantharam Kalya, Abisola Akinbobola, Herisse Sabulao and Sydney Mintalar. We appreciate your commitment to advancing treatment options for patients with acute decompensated heart failure. @BannerHealth #Aortix #heartfailure #cardiorenalsyndrome #diureticresistance #DRAINHF #clinicaltrials #innovation

💙 𝗛𝗮𝗽𝗽𝘆 𝗡𝘂𝗿𝘀𝗲 𝗣𝗿𝗮𝗰𝘁𝗶𝘁𝗶𝗼𝗻𝗲𝗿 𝗪𝗲𝗲𝗸! 💙 At @Procyrion , we’re proud to celebrate the dedication, compassion, and clinical excellence of 𝗡𝘂𝗿𝘀𝗲 𝗣𝗿𝗮𝗰𝘁𝗶𝘁𝗶𝗼𝗻𝗲𝗿𝘀 who make a difference every day. In our DRAIN-HF pivotal trial, Nurse Practitioners play a vital role in identifying and managing patients with 𝗮𝗰𝘂𝘁𝗲 𝗱𝗲𝗰𝗼𝗺𝗽𝗲𝗻𝘀𝗮𝘁𝗲𝗱 𝗵𝗲𝗮𝗿𝘁 𝗳𝗮𝗶𝗹𝘂𝗿𝗲 who may be eligible for enrollment. Their expertise ensures patients receive the best possible care — from early assessment through recovery. Your leadership, insight, and commitment drive meaningful advances in both 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 and 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀. Thank you for all you do to advance the art and science of patient care. #NursePractitionerWeek #ThankYou #HeartFailureCare #ClinicalResearch #DRAINHF #clinicaltrials #cardiorenalsyndrome #diureticresistance #Aortix #innovation

Thank you to all the DRAIN-HF sites that enrolled patients in Q3! Each patient brings us one step closer to our enrollment goal and to making Aortix available to the patients who need it most. Your commitment to advancing treatment options for patients with acute decompensated heart failure is an inspiration and the Procyrion team is grateful for the collaboration.

We had an incredible time at the 2nd annual Virginia Statewide Advanced Heart Failure Symposium! We’re especially grateful for the thoughtful conversations about the Aortix pump and the DRAIN‑HF pivotal trial that we had with clinicians and researchers who share our mission of improving treatment options for patients with acute decompensated heart failure. Thanks again to all the attendees, the @VCUHealth and @VCU_Surgery teams for hosting, and everyone who made the event so worthwhile and to Jessica M. from the Procyrion team. We look forward to continuing the dialogue and driving impact together! #Aortix #DRAINHF #HeartFailure #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation

We're still buzzing from our time at #HFSA2025! The Devices in Heart Failure and Heart Failure Society of America (@HFSA) meetings delivered inspiring science, practical insights, and energizing conversations. A heartfelt thank you to Dr. Sanjeev Gulati (@SanjeevGulatiMD) who shared insightful learnings from the DRAIN-HF pivotal study, and Dr. Liviu Klein (@LiviuKlein) who showcased how the Aortix pump’s unique mechanism of action can make a difference for patients being evaluated for dual organ transplants. We also appreciated the clinicians, researchers, and industry partners who stopped by our table to learn more about Aortix and the DRAIN-HF trial. We’re inspired by your passion and partnership as we work together to advance heart failure treatment. Can't wait for next year! #HFSADevices #Aortix #DRAINHF #clinicaltrials #heartfailure #cardiorenalsyndrome #diureticresistance #innovation

Today is 𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗮𝗿𝘁 𝗗𝗮𝘆: a reminder that cardiovascular disease remains the #1 cause of death worldwide, yet so much of it is preventable through awareness, early detection, and innovation in care. At Procyrion, we’re committed to advancing solutions for patients with acute decompensated heart failure and cardiorenal syndrome. Every enrollment in the DRAIN-HF trial and every new insight into the Aortix pump brings us closer to potentially transforming outcomes for those who need it most. Let’s use today to inspire action: to encourage everyone to be vigilant about their heart health, pay attention to their body's signals, and make lifestyle changes to prevent and manage cardiovascular diseases. #WorldHeartDay #DontMissABeat #HeartFailure #caradiorenalsyndrome #diureticresistance #DRAINHF #ClinicalTrials #Aortix #Innovation

The Procyrion team is headed to #HFSA2025 and looking forward to kicking things off tomorrow! Don't miss: 𝗧𝗿𝗶𝗮𝗹 𝗧𝗶𝗻𝗱𝗲𝗿 𝗦𝗲𝘀𝘀𝗶𝗼𝗻: Dr. Sanjeev Gulati (@SanjeevGulatiMD) will share insights on the pivotal DRAIN-HF study 𝗖𝗮𝘀𝗲 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻: Dr. Liviu Klein (@LiviuKlein) will highlight how the unique Aortix mechanism of action can make a difference for patients with advanced heart failure Stop by our table to learn more about the DRAIN-HF trial and the Aortix pump. We can’t wait to connect! #Aortix #DRAINHF #HFSADevices #clinicaltrials #heartfailure #cardiorenalsyndrome #diureticresistance #innovation

The Procyrion team is heading to #HFSA2025 next week! We're looking forward to hearing about the DRAIN-HF pivotal study from Dr. @SanjeevGulatiMD during the Trial Tinder session and an interesting case presentation from Dr. @LiviuKlein highlighting how the Aortix pump's unique mechanism of action can make a difference in advanced heart failure patients. We'll also have a table at the HFSA Devices in Heart Failure meeting so stop by to learn more about both the DRAIN-HF trial and Aortix. See you in Minneapolis! #DRAINHF #Aortix #heartfailure #cardiorenalsyndrome #diureticresistance #innovation

👏👏👏Shoutout to the outstanding team @BayCare Health System for your continued success in the DRAIN-HF pivotal trial! Your commitment and hard work are making a meaningful impact as we work together to advance treatment options for patients with acute decompensated heart failure. Every enrollment counts, and your dedication is helping drive this groundbreaking study forward. We're proud to partner with Nirav Y. Raval MD (@nyravalmd), Dr. Alok Singh, Dr. Firas Almahasneh, Dr. Meenakshi Bhalla, Arielle Campos BSN, RN, Christian Kelbaugh, Luis Sanchez Molina, BSN, RN, RRT, and Kim Braden and look forward to more milestones ahead! With Michael Dyess, Roxanne Thomas, and Kelly Mesa. #DRAINHF #Aortix #heartfailure #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation